Azithromycin or doxycycline for asymptomatic rectal chlamydia trachomatis
New England Journal of Medicine Jun 29, 2021
Lau A, Kong FYS, Fairley CK, et al. - Among homosexual men, rectal chlamydia is identified as a common bacterial sexually transmissible infection. Researchers conducted a double-blind trial at five sexual health clinics in Australia, randomizing 625 homosexual men who had asymptomatic rectal chlamydia to receive either doxycycline (100 mg twice daily for 7 days) or azithromycin (1-g single dose). Outcomes suggest superiority of a 7-day course of doxycycline vs single-dose azithromycin in the treatment of rectal chlamydia infection among these study participants.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries